NCT05013554
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05013554
Title Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | BEL

Facility Status City State Zip Country Details
~University of Texas - MD Anderson Cancer Center Site Number : 8400002 Houston Texas 77030 United States Details
Investigational Site Number : 0560002 Ghent 9000 Belgium Details
Investigational Site Number : 2500001 Pierre-Bénite 69495 France Details
Investigational Site Number : 2500002 Villejuif 94800 France Details
Investigational Site Number : 4100001 Seoul Seoul-teukbyeolsi 03080 South Korea Details
Investigational Site Number : 4100002 Seoul Seoul-teukbyeolsi 05505 South Korea Details
Investigational Site Number : 7240003 Barcelona Barcelona [Barcelona] 08035 Spain Details
Investigational Site Number : 7240001 Madrid Madrid, Comunidad de 28040 Spain Details
Investigational Site Number : 7240002 Madrid / Madrid Madrid, Comunidad de 28050 Spain Details
Investigational Site Number : 1580001 Taichung 404 Taiwan Details
Investigational Site Number : 1580002 Tainan 704 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field